Stefanos V Labropoulos

Summary

Publications

  1. pmc Imatinib in the treatment of dermatofibrosarcoma protuberans
    Stefanos V Labropoulos
    1st Medical Oncology Department, Hygeia Hospital, Marousi, Greece
    Biologics 1:347-53. 2007
  2. pmc Characterization of a novel large deletion and single point mutations in the BRCA1 gene in a Greek cohort of families with suspected hereditary breast cancer
    Ioulia Belogianni
    Molecular Biology Research Center HYGEIA Antonis Papayiannia, DTCA HYGEIA, 15123 Maroussi, Athens, Greece
    BMC Cancer 4:61. 2004
  3. ncbi request reprint Sustained complete remission of metastatic dermatofibrosarcoma protuberans with imatinib mesylate
    Stefanos V Labropoulos
    First Department of Medical Oncology, Hygeia Hospital, Marousi, Greece
    Anticancer Drugs 16:461-6. 2005

Collaborators

  • Jonathan A Fletcher
  • Ioulia Belogianni
  • Angela Apessos
  • Paris Kosmidis
  • Evangelia Razi
  • Antonios Keramopoulos
  • Nikos Pandis
  • Vasiliki Gaki
  • Andreas Petounis
  • Markos Mihalatos
  • Georgios Nasioulas
  • Andreas Hadjisavvas
  • Kyriacos Kyriacou
  • Drakoulis Yannoukakos

Detail Information

Publications3

  1. pmc Imatinib in the treatment of dermatofibrosarcoma protuberans
    Stefanos V Labropoulos
    1st Medical Oncology Department, Hygeia Hospital, Marousi, Greece
    Biologics 1:347-53. 2007
    ..Clinical evidence suggests that it has a role in locally advanced and metastatic disease and clinical trials are ongoing examining its role in this rare but potentially fatal sarcoma...
  2. pmc Characterization of a novel large deletion and single point mutations in the BRCA1 gene in a Greek cohort of families with suspected hereditary breast cancer
    Ioulia Belogianni
    Molecular Biology Research Center HYGEIA Antonis Papayiannia, DTCA HYGEIA, 15123 Maroussi, Athens, Greece
    BMC Cancer 4:61. 2004
    ..A multitude of mutations have been described and are found to be scattered throughout these two large genes. We describe analysis of BRCA1 in 25 individuals from 18 families from a Greek cohort...
  3. ncbi request reprint Sustained complete remission of metastatic dermatofibrosarcoma protuberans with imatinib mesylate
    Stefanos V Labropoulos
    First Department of Medical Oncology, Hygeia Hospital, Marousi, Greece
    Anticancer Drugs 16:461-6. 2005
    ..We conclude that sustained complete remission of metastatic DFSP with specific FISH abnormalities involving the PDGFB locus can be obtained with imatinib mesylate with minimal toxicity for the patient...